======= USP3 =======
== Gene Information ==
* **Official Symbol**: USP3
* **Official Name**: ubiquitin specific peptidase 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9960|9960]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6I4|Q9Y6I4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=USP3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604728|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Hydrolase that deubiquitinates monoubiquitinated target proteins such as histone H2A and H2B. Required for proper progression through S phase and subsequent mitotic entry. May regulate the DNA damage response (DDR) checkpoint through deubiquitination of H2A at DNA damage sites. Associates with the chromatin. {ECO:0000269|PubMed:17980597}.
|zf-UBP|
|UCH|
|histone deubiquitination|
|Flemming body|
|promoter-specific chromatin binding|
|cytoplasmic ribonucleoprotein granule|
|thiol-dependent ubiquitin-specific protease activity|
|histone binding|
|nuclear chromatin|
|protein deubiquitination|
|regulation of protein stability|
|protein modification by small protein removal|
|histone modification|
|covalent chromatin modification|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|DNA repair|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|mitotic cell cycle|
|protein catabolic process|
|chromatin organization|
|DNA metabolic process|
|cellular response to DNA damage stimulus|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|cellular macromolecule catabolic process|
|protein modification by small protein conjugation or removal|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|proteolysis|
|negative regulation of RNA metabolic process|
|cell cycle|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|cellular response to stress|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.94|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.94|
|[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-1.83|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.81|
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.73|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.72|
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.01|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.423|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5127
* **Expression level (log2 read counts)**: 5.96
{{:chemogenomics:nalm6 dist.png?nolink |}}